Evidence map›Paper›PMID 19155511›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation.

Estefania Claudio, Søren Ulrik Sønder, Sun Saret, Gabrielle Carvalho, Thirumalai R Ramalingam, Thomas A Wynn, Alain Chariot, Antonio Garcia-Perganeda, Antonio Leonardi, Andrea Paun and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 144 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Mouse Models of Psoriasis: A Comprehensive Review.The Journal of investigative dermatology · 2022
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Estefania ClaudioLaboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Søren Ulrik Sønder
Sun Saret
Gabrielle Carvalho
Thirumalai R Ramalingam
Thomas A Wynn
Alain Chariot
Antonio Garcia-Perganeda
Antonio Leonardi
Andrea Paun
Amy Chen
Nina Y Ren
Hongshan Wang
Ulrich Siebenlist
National Institutes of Health · US

Funding

Immunologic functions NF-kappaB factors and their regulatorsZIAAI000722 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MURPHY, PHILIP · 2009 to 2023
$13.8M
Approaches To Immunological Intervention In SchistosomiasisZIAAI000829 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WYNN, THOMAS · 2009 to 2018
$9.9M
Functions of IL-17 Family Cytokines in Health and DiseaseZIAAI001095 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SIEBENLIST, ULRICH · 2009 to 2020
$9.7M
Mechanisms of Fibrosis in Asthma and Other Fibroproliferative DiseasesZIAAI001019 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI WYNN, THOMAS · 2009 to 2018
$7.1M
IMMUNOMODULATORY FUNCTIONS OF THE NF-KB/IKB FAMILYZ01AI000722 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI SIEBENLIST, ULRICH · 1995 to 2008
$3.3M
Signaling Mechanisms of IL-17 Family CytokinesZIAAI001096 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SIEBENLIST, ULRICH · 2009 to 2013
$2.6M
MECHANISMS OF ACTIVATION OF NF-KB, A MEDIATOR OF THE IMMUNE RESPONSEZ01AI000723 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI SIEBENLIST, ULRICH · 1995 to 2008
$2.0M
The role of CCM2 in embryonic developmentZIAAI000431 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SIEBENLIST, ULRICH · 2009 to 2011
$503k
Intramural NIH HHS Z01 AI000722Intramural NIH HHS Z01 AI000723Intramural NIH HHS Z99 AI999999
6 · The paper itself

Abstract

IL-17 is the signature cytokine of recently discovered Th type 17 (Th17) cells, which are prominent in defense against extracellular bacteria and fungi as well as in autoimmune diseases, such as rheumatoid arthritis and experimental autoimmune encephalomyelitis in animal models. IL-25 is a member of the IL-17 family of cytokines, but has been associated with Th2 responses instead and may negatively cross-regulate Th17/IL-17 responses. IL-25 can initiate an allergic asthma-like inflammation in the airways, which includes recruitment of eosinophils, mucus hypersecretion, Th2 cytokine production, and airways hyperreactivity. We demonstrate that these effects of IL-25 are entirely dependent on the adaptor protein CIKS (also known as Act1). Surprisingly, this adaptor is necessary to transmit IL-17 signals as well, despite the very distinct biologic responses that these two cytokines elicit. We identify CD11c(+) macrophage-like lung cells as physiologic relevant targets of IL-25 in vivo.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBronchial HyperreactivityCD11c AntigenCells, CulturedHeLa CellsHumansImmunophenotypingInflammation MediatorsInterleukinsLungMacrophages, AlveolarMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutAdaptor Proteins, Signal TransducingCD11c AntigenInflammation MediatorsInterleukinsMydgf protein, mouseTraf3ip2 protein, mouse

Identifiers

PMID19155511
PMCPMC2630122
OpenAlexW2098658908

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.